HydraDAO
HydraDAO is a Swiss-registered DeSci DAO that funds and incubates biological replacement research—organ regeneration, spinal cord repair, and cryopreservation—to extend human lifespan, governed by HYDRA token holders via Snapshot and a Gnosis Safe treasury.
- Company typePrivate
- Founded-
- HeadquartersZürich, Switzerland
- Headcount11–50
- GTM typeB2C
- OfferingServices
What HydraDAO does
HydraDAO is a Decentralized Science (DeSci) DAO, registered as a Swiss association (HydraDAO Verein) in Zürich, that funds and incubates biological replacement research aimed at extending human lifespan. Its core scientific thesis is that an engineering approach to aging—replacing aged body parts with lab-grown or synthetic alternatives (organ transplants, cloned tissues, whole-body or brain replacement, spinal cord repair)—requires fewer fundamental biological breakthroughs than traditional repair-oriented longevity science. HydraDAO sources, evaluates, and funds these research projects through contributor working groups (Deal Flow, Operations, Awareness) and HYDRA token-holder governance.
HydraDAO's technology stack centres on the HYDRA ERC-20 governance token (18,626,879 total supply, 405 holders) traded on Uniswap, off-chain governance via Snapshot, and on-chain treasury management using a Gnosis Safe (proxied smart contract). The portfolio of funded projects includes Kind Bio's Integrated Organ Network (ION) platform for growing coordinated bodyoid organ systems ($250,000 strategic investment), Dowell Bio's Spinal Fusogens project for axonal fusion–based spinal cord repair ($380,700, with HydraDAO retaining 50% of resulting IP), and the American Biostasis Foundation's purpose-built cryopreservation facility in Comfort, Texas ($100,000 co-funded with CryoDAO). Treasury holdings of approximately $1,346,265.73 are concentrated in stETH (73.49%), HYDRA (13.79%), and ETH (9.35%).
HydraDAO has no commercial revenue model: the HYDRA token carries explicit disclaimers that it confers no dividends, revenue rights, or securities-like claims, and participants influence funding and IP commercialisation only through governance votes. The go-to-market motion is community-led, with contributions via Discord, content marketing, and Snapshot proposals as the principal channels for engaging academic researchers and DeSci community members. Geographic restrictions exclude United States–based token participants despite HydraDAO's US cryopreservation project, underscoring that the organization's commercial surface area is presently governance and research-deployment rather than product monetisation.
HydraDAO firmographics
Firmographics- Name
- HydraDAO
- Legal name
- HydraDAO Verein
- Website
- https://hydradao.org
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- HydraDAO is a Swiss-registered DeSci DAO that funds and incubates biological replacement research—organ regeneration, spinal cord repair, and cryopreservation—to extend human lifespan, governed by HYDRA token holders via Snapshot and a Gnosis Safe treasury.
- Ownership category
- akta.pro rank
HydraDAO industry classification
Industry- Product category
- Decentralized Science Research Funding
- NAICS
- Grantmaking Foundations (813211), Grantmaking and Giving Services (81321)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Monitoring, Evaluation, Learning (MEL) & Reporting for Donor Programs (BPADAOAL)
- akta.pro secondary industry
- Public Health Financing, Budgeting & Grants Management (HLAJAMAC)
Keywords
Where HydraDAO is headquartered
LocationHeadquarters
- HQ city
- Zürich
- HQ country
- Switzerland
- HQ region
- Europe
Offices3 records
Markets served
HydraDAO business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales
Revenue model
- Governance Token Economics: The HYDRA token serves as a governance token for the DAO. Token holders do not receive dividends or revenue rights but influence funding decisions and IP commercialization through governance. The token is available on Uniswap.
Go-to-market motion2 records
Distribution channels1 record
Marketing channels5 records
HydraDAO product offering
Product offeringCore offering
HydraDAO is a Decentralized Science (DeSci) DAO that funds and incubates replacement biology research aimed at radical human lifespan extension. Its core offerings consist of the HYDRA governance token (used to vote on research funding proposals and treasury management) and a portfolio of funded research projects, including Kind Bio's Integrated Organ Networks ($250,000), Dowell Bio's Spinal Fusogens ($380,700), and the American Biostasis Foundation cryopreservation facility ($100,000). The organization operates as a community-governed funding mechanism rather than a commercial product vendor.
Product overview
HydraDAO is a Decentralized Science (DeSci) DAO that functions as a funding and incubation organization for biological replacement research to extend human lifespan. The core offering consists of the HYDRA governance token, which provides holders with voting rights on research funding proposals and treasury management. HydraDAO's product portfolio includes three funded research projects: Kind Bio's Integrated Organ Networks (bodyoid platform for organ replacement, $250,000), Dowell Bio's Spinal Fusogens (spinal cord injury treatment using fusogen-based therapies, $380,700), and the American Biostasis Foundation's cryopreservation facility (long-term storage infrastructure, $100,000 co-funded with CryoDAO). Treasury operations are managed on-chain via Gnosis Safe with approximately $1.35M in assets.
Differentiator
Problem solved
Functional benefit
Products and services
- HYDRA Governance Token
Quantifiable outcome
- Applications typically receive response within 2 weeks of submission
Companies that use HydraDAO
Customer profileSegments2 records
Ideal customer profiles2 records
HydraDAO technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration5 records
Feature3 records
HydraDAO partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core, major and minor.
- Kind BiocoreHydraDAO partnered with Kind Bio with a $250,000 strategic investment to accelerate the development of replacement biology through bodyoids (integrated organ networks). Kind Bio is developing the Integrated Organ Network (ION) platform using artificial genomic constructs to grow coordinated sets of peripheral organs that develop and function together as a unified biological system.
- Dowell BiocoreFunding of $380,700 USDC for spinal cord injury research focusing on axonal fusion therapies using fusogens, neuroprotective strategies, and bioengineered scaffolds. Project aims to restore motor function and neural connectivity after complete spinal cord transection. HydraDAO retains 50% of IP developed.
- CryoDAOcoreCo-founding organization alongside HydraDAO, both founded to fund frontier research in their respective fields. Jointly funding the American Biostasis Foundation with 100,000 USDC each from initial 200,000 USDC request. CryoDAO focuses on cryopreservation research.
- American Biostasis FoundationcoreJoint venture with CryoDAO, Tomorrow Bio, and Cryopets to develop the first purpose-built long-term cryopreservation facility in the US (8,000-9,000 sqft, 1,000-2,000 patient capacity). Initial funding of 100,000 USDC from HydraDAO with STASIS token governance.
- Tomorrow BiomajorPartner in American Biostasis Foundation facility development. Will store patients at the facility from day one. Cryopreservation service provider affiliated with the ecosystem.
- CryopetsmajorPartner in American Biostasis Foundation facility development. Will store patients at the facility from day one. Pet cryopreservation service provider.
- Stasis Foundationmajor501(c)(3) nonprofit that acquired a 645-acre estate in Comfort, Texas with vision of creating a research park for cryonics. Provides land for American Biostasis Foundation facility.
- European Biostasis FoundationminorReferenced as the model for the American Biostasis Foundation. World's first purpose-built long-term cryopreservation facility opened in Switzerland in 2022, providing operational learnings and experience.
- VitaDAOminorDeSci ecosystem partner in longevity research. Shared contributor Si Maclennan works with both VitaDAO and CryoDAO/HydraDAO.
- Prime IntellectminorDeSci ecosystem partner. Co-founder Vincent Weisser co-founded Prime Intellect, BIO, CryoDAO, and VitaDAO.
- Longevity Biotech FellowshipminorLongevity ecosystem partner. Co-founder Nathan Cheng co-founded the Longevity Biotech Fellowship, Vitalism, and Healthspan Capital.
Scale indicators6 records
Recent moves5 records
Expansion highlights5 records
HydraDAO competitors and assessment
Company assessmentDirect peers
- VitaDAO: Decentralized science DAO funding longevity research via community governance and IP-tokenization. Closest functional peer: same DeSci model, same longevity thesis, overlapping founder network (Vincent Weisser, Si Maclennan).
- CryoDAO: DeSci DAO funding cryopreservation research; explicitly co-founded with HydraDAO and shares multiple core contributors (Vincent Weisser, Emil Kendziorra). Same funding-and-IP model, sister focus area in the replacement/longevity stack.
Broad incumbents
- Molecule: DeSci infrastructure platform for IP-NFT funding of early-stage research; operates as an enabling protocol that DAOs like HydraDAO and VitaDAO use to structure funding rounds and IP rights.
- Bio.xyz: DeSci accelerator and ecosystem-incubator spinout from Molecule; comparable as a broader DeSci platform that supports numerous BioDAOs across modalities (longevity, women's health, psychedelics).
- Methuselah Foundation: Established nonprofit foundation funding longevity and tissue-engineering research (including organ printing initiatives); comparable as a longevity grantmaker, but with traditional foundation governance rather than DeSci token structure.
- SENS Research Foundation: Long-running research foundation focused on the damage-repair theory of aging; comparable to HydraDAO as a funder/incubator of regenerative medicine and longevity science, though operating as a classical 501(c)(3).
- Longevity Science Foundation: Decentralized longevity research funding organization that awards grants from a community-governed treasury; mirrors HydraDAO's model but at a broader thematic (longevity) level rather than replacement-biology specific.
- Impetus Grants: Nonprofit longevity research funding initiative; comparable as a peer grantmaking body advancing the same field, though using conventional philanthropic funding rather than DeSci infrastructure.
Emerging players
- AthenaDAO: DeSci DAO funding women's health and reproductive longevity research; uses the same governance-token/treasury model as HydraDAO but with a narrower therapeutic focus.
- PsyDAO: DeSci DAO funding psychedelic and mental-health research; same structural template (token governance, USDC-denominated research funding, IP retention) as HydraDAO but in an adjacent therapeutic area.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
HydraDAO social profiles
Digital presenceHydraDAO financial estimates
Financial estimateRevenue estimate
Valuation estimate
HydraDAO leadership team
Management profileNumber of profiles
Profiles4 records
HydraDAO funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
HydraDAO M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about HydraDAO
What does HydraDAO do?
HydraDAO is a Decentralized Science (DeSci) DAO that funds and incubates replacement biology research aimed at radical human lifespan extension. Its core offerings consist of the HYDRA governance token (used to vote on research funding proposals and treasury management) and a portfolio of funded research projects, including Kind Bio's Integrated Organ Networks ($250,000), Dowell Bio's Spinal Fusogens ($380,700), and the American Biostasis Foundation cryopreservation facility ($100,000). The organization operates as a community-governed funding mechanism rather than a commercial product vendor.
Is HydraDAO a public or private company?
HydraDAO is a private company. It is classified as unknown and is currently operating.
When was HydraDAO founded?
HydraDAO was founded in -1. It employs 11 to 50 people.
Where is HydraDAO based?
HydraDAO is headquartered in Zürich, Switzerland, in the Europe region.
How does HydraDAO make money?
One revenue line is on record: governance Token Economics.
Who are HydraDAO's main competitors?
Direct peers on record are VitaDAO and CryoDAO. Broad incumbents are Molecule, Bio.xyz, Methuselah Foundation, SENS Research Foundation, Longevity Science Foundation and Impetus Grants. Emerging players are AthenaDAO and PsyDAO.
Does HydraDAO have an API?
No public API is recorded for HydraDAO.
What industry is HydraDAO in?
HydraDAO's product category is Decentralized Science Research Funding. Its primary akta.pro industry code is BPADAOAL, Monitoring, Evaluation, Learning (MEL) & Reporting for Donor Programs, with a secondary code of HLAJAMAC, Public Health Financing, Budgeting & Grants Management. Its NAICS code is 813211 and its SIC code is 8731.